In vivo characteristics of low molecular weight copoly(L-lactic acid/glycolic acid) formulations with controlled release of luteinizing hormone-releasing hormone agonist

Journal of Controlled Release

Volumn 9, Issue 2, 1989, Pages 111-122

  Masaharu, Asano ^a   Hironobu, Fukuzaki ^a   Masaru, Yoshida ^a   Minoru, Kumakura ^a   Tooru, Mashimo ^b   Hisako, Yuasa ^b   Kyoichi, Imai ^b   Hidetoshi, Yamanaka ^b   Keiji, Suzuki ^c  

^a TAKASAKI ADVANCED RADIATION RESEARCH INSTITUTE   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOLIC ACID; LACTIC ACID; LEUPRORELIN; POLYMER;

ANIMAL EXPERIMENT; DRUG RELEASE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0024319040     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-3659(89)90002-3     Document Type: Article

References (32)

1. Polylactic acid as a biodegradable carrier for contraceptive steroids
2. An injectable sustained release fertility control system
3. Biodegradable systems for the sustained release of fertility-regulating agents
4. Sustained drug delivery systems. I. The permeability of poly(ϵ-caprolactone), poly(dl-lactic acid), and their copolymers
5. Biodegradable hollow fibres for the controlled release of drugs
6. Long-acting delivery systems for narcotic antagonists. 1
7. Lactic/glycolic acid polymers as narcotic antagonist delivery systems
8. In vivo and in vitro evaluation of a microencapsulated narcotic antagonist
9. Sustained release of an antimalarial drug using a copolymer of glycolic/lactic acid
10. Sustained release of sulphadiazine
11. Influence of physicochemical properties of polylactic acid on the characteristics and in vitro release patterns of polylactic acid microspheres containing local anesthetices
12. Preparation and evaluation in vitro and in vivo of polylactic acid microspheres containing dibucaine
13. Biodegradability of a hot-pressed poly(lactic acid) formulation with controlled release of LH-RH agonist and its pharmacological influence on rat prostate
14. Controlled release of a luteinizing hormone-releasing hormone analogue from poly(d,l-lactide-co-glycolide) microspheres
15. Prolonged controlled-release of nafarelin, a luteinizing hormone-releasing hormone analogue, from biodegradable polymer implants: Influence of composition and molecular weight of polymer
16. Preliminary report on use of depot formulation of LHRH analogue ICI 118630 (Zoladex) in patients with prostatic cancer
17. Radioimmunoassay for 6-d-tryptophan analog of luteinizing hormone-releasing hormone: Measurement of serum levels after administration of long-acting microcapsule formulations
18. Time-release depot for anticancer agents
19. Development and application of a needle shaped anticancer drug-polymer composite
20. Study on slow released anticancer drug — polyglycolic acid
21. Study on 5-FU-polylactic acid microcapsules
22. Experimental study of an anticancer drug delivery system using polylactic acid
23. Fusibility of poly(N-carboxy α-amino acid anhydride) materials treated under pressure-heat conditions and in vitro-in vivo degradation of hot-pressed materials
24. Pharmacological response in male rats with controlled release formulations of luteinizing hormone-releasing hormone agonist
25. Aliphatic polyesters III The synthesis and properties of polylactide
26. Calibration in gel permeation chromatography: Primary, universal and empirical methods
27. Polylactones 3 Copolymerization of glycolide with ll-lactide and other lactones
28. Effect of drug-vinyl copolymer delivery composite on the rat prostate
29. A radioimmunoassay for a high active luteinizing hormone-releasing hormone analogue and relation between the serum level of the analogue and that of gonadotropin
30. Radioimmunoassay of sex steroid hormones
31. Direct copolymerization of l-lactic acid with δ-valerolactone in the absence of catalysts
32. Biodegradable polymers for use in surgery